{"disease":{"id":"refractory-immune-cytopenias","name":"refractory immune cytopenias"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05873205","title":"Open-Label, Phase II Trial of Isatuximab for Patients With Refractory Immune Cytopenias After Allogeneic Hematopoietic Cell Transplantation","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":12,"lead_sponsor_name":"Memorial Sloan Kettering Cancer Center","has_results":false}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}